Mary A. Driscoll

Mary A. Driscoll

Auto-generated profile, based on publicly available information

Mary A. Driscoll

VA Connecticut Healthcare System, West Haven, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2015 in Annals of Behavioral Medicine
Verified
Journal Article
Open access
PDF file
MDMary A. Driscoll
Mary A. Driscoll
MDMary C. Davis
Mary C. Davis
LALeona S. Aiken
Leona S. Aiken
EYEllen W. Yeung
Ellen W. Yeung
ESEvelina Weidman Sterling
Evelina Weidman Sterling
LNLawrence M. Nelson
Lawrence M. Nelson
Background. The infertility associated with primary ovarian insufficiency (POI) presents significant emotional challenges requiring psychosocial adjustm

21 September 2017 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
AHAlicia A. Heapy
Alicia A. Heapy
LWLaura Wandner
Laura Wandner
MDMary A. Driscoll
Mary A. Driscoll
KLKathryn LaChappelle
Kathryn LaChappelle
RCRebecca Czlapinski
Rebecca Czlapinski
RKRobert Kerns
Robert Kerns

1 September 2021 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
LBLori A. Bastian
Lori A. Bastian
MDMary Driscoll
Mary Driscoll
EDEric DeRycke
Eric DeRycke
SESara Edmond
Sara Edmond
KMKristin Mattocks
Kristin Mattocks
WBWilliam Becker
William Becker
Smoking is associated with greater pain intensity and pain-related functional interference in people with chronic pain. Interventions that teach smokers with chronic pain how to apply adaptive coping strategies to promote both smoking cessation and pain self-management may be effective. The Pain and Smoking Study (PASS) is a randomized clinical trial of a telephone-delivered, cognitive behavioral intervention among Veterans with chronic pain who smoke cigarettes. PASS participants are randomized to a standard telephone counseling intervention that includes five sessions focusing on motivational interviewing, craving and relapse management, rewards, and nicotine replacement therapy versus the same components with the addition of a cognitive behavioral intervention for pain management. Participants are assessed at baseline, 6, and 12 months. The primary outcome is smoking cessation. The 371 participants are 88% male, a median age of 60 years old (range 24-82), and smoke a median of 15 cigarettes per day. Participants are mainly white (61%), unemployed (70%), 33% had a high school degree or less, and report their overall health as "Fair" (40%) to "Poor" (11%). Overall, pain was moderately high (mean pain intensity in past week = 5.2 (Standard Deviation (SD) = 1.6) and mean pain interference = 5.5 (SD = 2.2)). Pain-related anxiety was high (mean = 47.0 (SD = 22.2)) and self-efficacy was low (mean = 3.8 (SD = 1.6)). PASS utilizes an innovative smoking and pain intervention to promote smoking cessation among Veterans with chronic pain. Baseline characteristics reflect a socioeconomically vulnerable population with a high burden of mental health comorbidities.

1 September 2018 in Pain Medicine
Verified
Journal Article
Open access
MDMary A Driscoll
Mary A Driscoll
EPElliottnell Perez
Elliottnell Perez
SESara N Edmond
Sara N Edmond
WBWilliam C Becker
William C Becker
EDEric C DeRycke
Eric C DeRycke
LBLori A Bastian
Lori A Bastian
Objective. High rates of co-occurring smoking and chronic pain are observed in the veteran population. Individuals who smoke and have chronic pain report lower self-efficacy to quit and are less successful in their attempts. Design. In this pilot study, we assess the feasibility of a telephone-delivered intervention designed to integrate evidencebased smoking cessation and pain management components in a way that allows patients to understand the interplay between the two while attempting to have them build off each other and develop coping skills to address both concerns. Patients. Study participants (N = 7) were veterans who received primary care in the VA Healthcare System and reported current smoking and a worst pain intensity score of 4 or greater. Intervention. A five-session telephone intervention was delivered over eight weeks. Participants completed a survey at baseline and 10-week follow-up. Outcome Measures. Feasibility was assessed by examining engagement with the intervention. Results. Four out of seven participants completed all five sessions. Two out of seven veterans reported quitting smoking, and five out of seven reported clinically meaningful improvements in pain intensity and functional interference. Conclusions. Insights gained from this study were used to modify an intervention being examined in a randomized controlled trial to test its effectiveness on both smoking and pain outcomes.

20 March 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
RMR Ross MacLean
R Ross MacLean
BABrett Ankawi
Brett Ankawi
MDMary A Driscoll
Mary A Driscoll
MGMelissa A Gordon
Melissa A Gordon
TFTami L Frankforter
Tami L Frankforter
AHAlicia A Heapy
Alicia A Heapy
Background: Chronic pain is common among individuals with opioid use disorder (OUD) who are maintained on medications for OUD (MOUD; eg, buprenorphine or methadone). Chronic pain is associated with worse retention and higher levels of substance use. Treatment of individuals with chronic pain receiving MOUD can be challenging due to their increased clinical complexity. Given the acute and growing nature of the opioid crisis, MOUD is increasingly offered in a wide range of settings, where high-quality, clinician-delivered, empirically validated behavioral treatment for chronic pain may not be available. Therefore, digital treatments that support patient self-management of chronic pain and OUD have the potential for wider implementation to fill this gap. Objective: This study aims to evaluate the efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT), an interactive digital treatment program with asynchronous coach feedback, compared to treatment as usual (TAU) in individuals with chronic pain and OUD receiving MOUD. Methods: Adult participants (n=160) receiving MOUD and reporting bothersome or high-impact chronic pain will be recruited from outpatient opioid treatment programs in Connecticut (United States) and randomized 1:1 to either IMPACT+TAU or TAU only. Participants randomized to IMPACT+TAU will complete an interactive digital treatment that includes 9 modules promoting training in pain and addiction coping skills and a progressive walking program. The program is augmented with a weekly personalized voice message from a trained coach based on daily participant-reported pain intensity and interference, craving to use opioids, sleep quality, daily steps, pain self-efficacy, MOUD adherence, and engagement with IMPACT collected through digital surveys. Outcomes will be assessed at 3, 6, and 9 months post randomization. The primary outcome is MOUD retention at 3 months post randomization (ie, post treatment). Secondary outcomes include pain interference, physical functioning, MOUD adherence, substance use, craving, pain intensity, sleep disturbance, pain catastrophizing, and pain self-efficacy. Semistructured qualitative interviews with study participants (n=34) randomized to IMPACT (completers and noncompleters) will be conducted to evaluate the usability and quality of the program and its outcomes. Results: The study has received institutional review board approval and began recruitment at 1 site in July 2022. Recruitment at a second site started in January 2023, with a third and final site anticipated to begin recruitment in January 2024. Data collection is expected to continue through June 2025. Conclusions: Establishing efficacy for a digital treatment for addiction and chronic pain that can be integrated into MOUD clinics will provide options for individuals with OUD, which reduce barriers to behavioral treatment. Participant feedback on the intervention will inform updates or modifications to improve engagement and efficacy. Trial Registration: ClinicalTrials.gov NCT05204576; https://clinicaltrials.gov/ct2/show/NCT05204576 International Registered Report Identifier (IRRID): DERR1-10.2196/54342

10 April 2020 in Military Behavioral Health
Verified
Journal Article
Closed access
Joan CombellickJoan Combellick
Joan Combellick
AGAllison E. Gaffey
Allison E. Gaffey
MDMary A. Driscoll
Mary A. Driscoll
TFTeresa Foley
Teresa Foley
SRSilvia Ronzitti
Silvia Ronzitti
SHSally G. Haskell
Sally G. Haskell
Introduction: This study aimed to investigate the relationship between military-related traumatic experiences and postpartum depression in a cohort of post-9/11 women veterans. We hypothesized that women veterans would report high rates of postpartum depression, and that military-related traumas would constitute unique risk factors for postpartum depression. Methods: This cross-sectional study was based on survey data from post-9/11veterans who were discharged and gave birth between October, 2001 and September, 2015. Bivariate and multivariate analyses included military-related trauma variables, demographics, and factors that have been previously associated with postpartum depression in other populations. Results: Based on multivariate analyses of 151 respondents, 41% of women reported a definite or possible history of postpartum depression. Military exposures, namely multiple deployments (OR = 2.41, CI = 1.06-5.50), and combat exposure (OR= 1.05, CI = 1.01-1.10), were predictive of postpartum depression following the most recent, post-deployment pregnancy. Discussion: These findings suggest that military-related factors may increase the risk for postpartum depression among women veterans. Clinicians should be vigilant in screening for military service and exposures to provide early referral and additional support as needed.